Clonidine may have beneficial effects in patients undergoing major surgery. We enrolled 156 patients having elective CABG surgery in a double-blind, randomized trial. Patients were randomized to receive either two doses of placebo (Group PP) or clonidine 5 µg/kg (Group CC). Perioperative measurements included haemodynamics, anaesthetic and analgesic drug usage, creatinine clearance, cortisol excretion, recovery times and quality of life (SF-36) after surgery. Overall, there was no significant difference with time to tracheal extubation (median [10-90 centile]): CC 7.1(3.4-18) h vs PP 8.0(4.3-17) h, P=0.70; but there was a higher proportion of patients extubated within four hours: CC 20% vs. PP 8%, P=0.038. Clonidine resulted in a number of significant (P<0.05) haemodynamic changes, particularly pre-CPB: less tachycardia and hypertension, more bradycardia and hypotension. Clonidine was associated with a significant (P<0.05) reduction in anaesthetic drug usage, higher creatinine clearance, lower cortisol excretion and improvement in some aspects of quality of life. This study lends support to consideration of clonidine therapy in patients undergoing CABG surgery.
Anaesthesia for coronary artery bypass graft (CABG) surgery is complicated by the patient's preexisting heart disease and the nature of the surgery, which includes episodes of intense surgical stimulation and cardiopulmonary bypass (CPB). In the 1990s emphasis has focused on early tracheal extubation and faster recovery after cardiac surgery, with largedose opioid anaesthesia being replaced by inhalational or intravenous techniques 1, 2 .
Clonidine, a centrally-acting alpha 2 -agonist, may promote perioperative haemodynamic stability, reduce myocardial ischaemia, improve renal function, provide sedation and anxiolysis, reduce anaesthetic and analgesic requirements and attenuate the neurohumoral "stress response" of major surgery [3] [4] [5] [6] [7] [8] [9] [10] . These effects have not been reported in patients undergoing CABG surgery with a propofol-based technique, where early extubation can be achieved. Controversy also exists however, with some authors arguing that the supposed beneficial effects of alpha 2 -agonists are insufficient to recommend their widespread use in anaesthesia 11 , although there remains strong support for routine use in cardiac and vascular surgery [3] [4] [5] [6] [8] [9] [10] 12 . Dorman et al studied the effect of clonidine in 43 patients undergoing elective CABG surgery and found a significant reduction in the amount of ST-segment depression and myocardial lactate production 6 . They concluded that perioperative treatment with clonidine reduces myocardial ischaemia, although they also found a greater need for cardiac pacing following CPB and persistently lower cardiac output. Previous authors had found similar results in unblinded studies 3, 5 . While most published information supports the use of clonidine in cardiac surgery, there is reason for caution. Abi-Jaoude et al, in a double-blind study of 24 patients undergoing elective CABG surgery using high-dose alfentanil anaesthesia, concluded that clonidine resulted in an unstable haemodynamic status postoperatively with severe hypotension occurring frequently 11 . These conflicting opinions remain unresolved, and the potential benefits of less myocardial ischaemia and postoperative myocardial infarction, together with reduced anaesthetic drug doses allowing faster and smoother recovery using propofol, warrant further investigation. This prospective, randomized, doubleblind study was designed to investigate whether clonidine improves outcome after CABG surgery.
METHODS
After Ethics Committee approval, we approached all eligible elective CABG surgical patients and obtained written, informed consent. Patients were excluded if they were currently receiving clonidine or alpha-methyldopa, were allergic to trial medications, considered at very high risk (defined as a clinical severity score >9 13 ), were hypotensive (systolic blood pressure <120 mmHg), had congestive cardiac failure or an ejection fraction <25%. Patients were also excluded if they had atrial fibrillation, atrioventricular or left bundle branch block detected on their preoperative electrocardiogram (ECG), or had a pacemaker in situ (preventing ST-segment diagnosis of perioperative myocardial ischaemia).
Because recovery and complications following CABG surgery are related to left ventricular (LV) function, stratified randomization of the LV angiographic appearance (1. none-mild LV impairment, or 2. moderate LV impairment) was used to maximize equality for both groups. Block randomization was performed independently by our pharmacy department.
Anaesthetic Technique
Medications, including nitrates, β-adrenergic blockers and calcium-channel blockers, were continued until the time of operation. All patients received a standard premedication of oral temazepam 10-20 mg, intramuscular morphine 5-10 mg and oxygen delivered via face mask at 5 l/min. The first dose of trial medication (patients randomized to oral clonidine 5 µg/kg or placebo) was administered at the time of premedication, approximately 1.5 hours before surgery. Trial medication was prepared and coded by the pharmacy department, with investigators and patients blinded to its identity.
Patient monitoring consisted of five-lead ECG, pulse oximetry, capnography, invasive arterial pressure (via radial or brachial artery) and pulmonary artery pressure (via right internal jugular vein). The ECG and pulse oximeter were placed on arrival in the operating suite before insertion of intravascular catheters. Correct ST-segment monitoring was confirmed (with definition of isoelectric line and J point). The arterial and pulmonary arterial catheters were inserted with local anaesthesia before induction but without intravenous (I-V) sedation.
All patients had an identical induction technique consisting of a propofol infusion induction at 8 mg.kg -1 .hr -1 until loss of eyelash reflex, whereupon intravenous midazolam 50 µg/kg and fentanyl 10 µg/kg were administered. Muscle relaxation and endotracheal intubation followed intravenous pancuronium 0.12 mg/kg. Vecuronium 2 to 4 mg was given if patient movement occurred intraoperatively.
The propofol infusion was reduced to 5 mg.kg -1 .hr -1 immediately after endotracheal intubation and further reduced to 3 mg.kg -1 .hr -1 following sternotomy. Incremental boluses of propofol 0.2 mg/kg were administered if the patient's mean systemic blood pressure (MBP) exceeded 85 mmHg. Management of hypertension, hypotension and bradycardia were dictated by a predetermined protocol (see Appendix).
Patients were ventilated with a tidal volume of 10 ml/kg, adjusting respiratory rate to an end-tidal carbon dioxide of 32 to 34 mmHg; positive endexpiratory pressure was not used. A second dose of trial medication (either clonidine 5 µg/kg or placebo), followed by 20 ml water (to flush), was given via an orogastric tube immediately before CPB. CPB was standardized using a crystalloid/colloid prime, membrane oxygenator, moderate hypothermia (27-32°C) and alpha-stat pH management. Myocardial protection consisted of intermittent anterograde and/or retrograde blood cardioplegia.
On occasion, the anaesthetist considered the patient's clinical status enabled immediate extubation following completion of surgery before transfer to ICU. For the majority of cases however, patients remained intubated and mechanically ventilated for transfer. Patients were weaned from mechanical ventilation as soon as they responded to verbal stimuli, were normothermic, haemodynamic stability had been established and blood loss was satisfactory (<100 ml/hr). Analgesia was provided by a morphine sulphate infusion with the rate adjusted by an ICU nurse (according to the physician's orders). If patient agitation did not respond to morphine sulphate, midazolam or propofol sedation was administered. Extubation occurred when the patient was awake and cooperative, with a respiratory rate between 10 and 20 breaths/min and satisfactory arterial blood gas tensions.
Measurements
Haemodynamics: (MBP), heart rate (HR), central venous pressure (CVP), pulmonary capillary wedge pressure (PCWP), cardiac index (CI), systemic vascular resistance (SVR), pulmonary vascular resistance (PVR), left ventricular stroke work index (LVSWI) were determined within two minutes of the following time periods: 1) pre-induction, 2) five minutes post-induction, 3) five minutes poststernotomy, 4) 10 minutes post-CPB, 5) post-sternal closure, 6) ICU admission, 7) 4 hours post-ICU admission, 8) 12 hours post-ICU admission.
Cardiac output was measured using the thermodilution method (10 ml room-temperature saline at end-expiration, in triplicate). ST-segment analysis and derived indices were calculated using the Hewlett-Packard Component Monitoring System (HP M1176A, Hewlett-Packard GmbH, Hamburg, Germany).
Arterial and mixed venous blood samples were taken to calculate oxygen delivery (DO 2 ), consumption (VO 2 ) and extraction ratio (O 2 ER) at three time points (pre-induction, post-sternotomy, and post-CPB immediately following sternal closure). During the first 12 hours of their recovery in ICU, patients were categorized by their nurse to have shivered or not .
The amount of propofol used at induction and total propofol dose for the procedure were documented. Blood was taken via the arterial line for estimation of arterial propofol levels immediately before CPB in a convenience sample of patients (n=57). Plasma samples were stored at 4°C for later estimation of plasma propofol concentrations using a HPLC technique; the coefficient of variation for replicate determinations at a plasma propofol concentration of 0.5 µg/ml was 0.75%.
Three-lead (II, aVL and V5) ST-segment analysis was used to detect intraoperative myocardial ischaemia. Ischaemia was defined as ST-segment depression >1 mm, or elevation >2 mm, at 60 ms after the J point, persisting for at least two minutes (confirmed with real-time visual check). A 12-lead ECG was performed on admission to ICU and daily for three days after surgery. Blood was taken at 36 hours for creatine kinase (CK)-MB fraction. Acute myocardial infarction was diagnosed if new Q waves appeared in at least two ECG leads, as detected by an independent and blinded cardiologist, and CK-MB fraction >5%.
Renal function was assessed by measuring creatinine clearance intraoperatively (first four hours postinduction) and for four hours post-ICU admission. Serum creatinine was also measured on day 5 postoperatively. Urinary cortisol excretion was also determined from both four-hourly urine collections in 40 patients as an indicator of neurohumoral stress response.
Sedative (midazolam, propofol) and analgesic (morphine) usage were documented for the first 24 hours following ICU admission. Times to extubation (from ICU admission) and "fitness for discharge" from ICU* were recorded.
Quality of life was measured preoperatively and at one and six months postoperatively, using the modified SF-36 14 . This is a concise 36-item health status questionnaire measuring eight dimensions: physical functioning (10 items), social functioning (2 items), role limitations due to physical problems (4 items), role limitations due to emotional problems (3 items), mental health (5 items), energy/vitality (4 items), pain (2 items) and general health perception (5 items).
Sample Size Calculation
A preliminary estimate of sample size was based on Dorman et al's study of clonidine and CABG surgery 6 . With an expected difference of proportions between clonidine and placebo groups with respect to incidence of myocardial ischaemia (4% vs 38%), accepting a type I error of 0.01 and a type II error of 0.05, the required number was calculated at 110 patients (Clinical Trials Design Program V1.0, Biosoft, Cambridge, U.K.). This sample size also provided adequate power (>90%) to detect a significant difference in time to extubation 2 . One hundred and fifty patients were included in this study to allow more meaningful secondary analyses.
The primary endpoints were time to extubation and incidence of myocardial ischaemia. The secondary endpoints were perioperative haemodynamic changes, O 2 ER, creatinine clearance, cortisol excretion, drug requirements, time to ICU discharge, quality of life, and adverse events (inotrope and vasoconstrictor use, cardiac pacing, acute myocardial infarct rate). 139 Continuous data were assessed for normality using the Kolmogorov-Smirnov test, then analyzed using unpaired, two-tailed Student's t-test or repeated measures analysis of variance (MANOVA) and are presented as mean(SD). LV function is included as a covariate for the analysis of haemodynamic and ST-segment data. Abnormally distributed data were analysed using the Mann-Whitney U-test and are presented as median (10th-90th centile). Proportions were analysed by chi-square or Fisher's exact test and are presented as number(%). Time to tracheal extubation was analysed using the logrank test. Selective multivariate logistic and linear regression analyses were performed to identify predictors of time to tracheal extubation, cardiac pacing after CPB and fitness for discharge from ICU. All statistical analyses were performed with investigators blinded to knowledge of group identity, using SPSS/PC+ V4.0 (SPSS Australasia Ltd, Sydney); the code was then broken. A Bonferroni correction was applied for the analysis of the multiple haemodynamic and quality of life variables. A P value of less than 0.05 was considered significant for other trial endpoints.
CLONIDINE AND CARDIAC SURGERY

RESULTS
A total of 156 patients (128 male, 28 female) were enrolled in this study, with subsequent exclusion of six patients (one patient required emergency surgery, three patients failed to receive their allotted study medication and two had unplanned concurrent valvular surgery). This left 150 patients with an average age of 65(10) years, aortic cross-clamp time of 55 (16) minutes and duration of surgery of 4.0 (0.9) hours. No patient reported intraoperative awareness. Six patients had severe postoperative complications resulting in prolonged ICU stay (3 clonidine group, 3 placebo group), including two postoperative deaths (both placebo group). There were 76 patients in the clonidine group and 74 patients in the placebo group. The groups were well-matched for most perioperative factors though there were more women in the placebo group (Table 1) .
There were no significant differences in the time to extubation or fitness for discharge from ICU ( Figure  1 ), although more patients were extubated early (<4 hours) in the clonidine group, 15 (20%) versus 6 (8%), (P=0.038). In those patients less than 65 years for which there were similar inter-group baseline characteristics (results not shown), there was a significant difference in median time to extubation: clonidine group 5.6 (2-13) hours versus placebo group 7.4 (2.5-30) hours (P=0.036). There was no difference in time to ICU discharge, clonidine group 16 hours versus placebo group 16 (7-48) hours (P=0.65). The groups had a similar rate of intraoperative myocardial ischaemia and postoperative myocardial infarction ( Table 2) .
Clonidine resulted in a number of significant haemodynamic changes, particularly pre-CPB ( Figure 2 ): HR, MBP, PCWP, SVR, LVSWI and CI, but not for PVR. In general, patients in the clonidine group were more likely to have a slower HR, and a lower MBP, SVR, CI and LVSWI. Most of these differences did not persist after CPB, except MBP and SVR, and to a lesser extent LVSWI. Despite these haemodynamic differences, there was no difference between the groups for vasoconstrictor requirement (P=0.16) or inotropic support (P=0.74) ( Table 3) .
Patients in the clonidine group required a lower infusion rate of nitroglycerin (NTG) postoperatively (Table 3) . Patients in the clonidine group had a higher incidence of pre-CPB bradycardia and hypotension, and post-CPB cardiac pacing ( Clonidine significantly improved early postoperative renal function (as measured by creatinine clearance, (Figure 3) ), but this did not persist to day 5 (as measured by serum creatinine: clonidine group 96 (19) µmol/l versus placebo group 100 (26) µmol/l). There was also some evidence of a decrease in the neurohumoral stress response (as measured by urinary cortisol excretion), particularly during the early postoperative period (Figure 3) . Clonidine resulted in a significant reduction in DO 2 preinduction, but not post-sternotomy or post-CPB (Figure 4) , and a significant increase in O 2 ER preinduction and also after sternal closure (Figure 4) . Clonidine significantly modulated the anaesthetic and postoperative sedative requirements, though there was no difference in the resultant plasma propofol concentration ( Table 4 ). The mean (95% confidence interval) for plasma propofol concentration in all patients was 2.18 (1.9-2.5) µg/ml.
There was a significant improvement in general health perceptions (quality of life) at one month postoperatively in patients receiving clonidine (Table 5) .
Multivariate predictors of cardiac pacing after CPB included increased patient age (P<0.001) and treatment with clonidine (P=0.014); predictors of time to fitness for discharge from ICU were preoperative left ventricular function, as assessed by LV angiography (P=0.012), the clinical severity score (P=0.05) 14 , and increased post-CPB O 2 ER (P=0.021). The only significant multivariate predictor of time to tracheal extubation was increased post-CPB O 2 ER (P=0.002).
DISCUSSION
This is the first double-blind, randomized trial comparing the effects of clonidine in patients having CABG surgery with a propofol-based technique to include patients with unstable angina and known impairment of LV contractility. In all, 31% of patients were receiving IV NTG and/or IV heparin at the time of surgery and 39% had moderate or severe LV impairment. Our study population is typical of current cardiac surgical practice in many institutions.
Time to Tracheal Extubation
This study found no significant difference with time to tracheal extubation or ICU discharge. There have been conflicting reports of clonidine's effect on recovery times after noncardiac surgery 10, 15 , but there have been no reports of clonidine delaying recovery after cardiac surgery employing high-dose opioid techniques 5 . Because we had expected (and observed) a lower requirement for anaesthetic and sedative agents in the clonidine group, we had also expected a faster recovery and a shorter time to tracheal extubation. Further analyses found that more patients were extubated early in the clonidine group (less than four hours), and in patients aged less than 65 years there was a significantly shorter median time to extubation. This suggests that clonidine may be a useful adjunct if early extubation after cardiac surgery is contemplated (particularly in younger, low-risk patients). This potential benefit has significant cost implications and warrants further investigation.
Perioperative Myocardial Ischaemia
We found a similar rate of intraoperative myocardial ischaemia and postoperative myocardial infarction in both groups. However, because of the low incidence of these events in this study, confident conclusions regarding the potential efficacy of clonidine with respect to myocardial ischaemia cannot be made. Definitive information requires more sensitive markers of ischaemia 6, [16] [17] and a longer period of monitoring (ideally for at least 24 hours) using Holter technology [17] [18] [19] . Dorman et al reported a marked reduction in myocardial ischaemia in patients undergoing CABG surgery using clonidine (from 38% to 4%) 6 . Stuhmeier et al reported a reduction in the incidence of perioperative myocardial ischaemia from 39% to 26% using clonidine (2 µg/kg) in 297 patients having vascular surgery 8 . As there may be a relationship between the neurohumoral stress response, tachycardia and postoperative myocardial ischaemia 12, 19 , it is conceivable that alpha 2 -agonists such as clonidine may reduce rates of perioperative myocardial infarction, though this remains to be convincingly demonstrated.
Perioperative Haemodynamic Effects
This study demonstrates that clonidine has significant haemodynamic effects which are most prominent during the pre-CPB period. Clonidine resulted in less tachycardia and hypertension, but also more bradycardia and hypotension, as well as a greater need for cardiac pacing after CPB. No further haemodynamic effects were observed post-CPB until admission to ICU, when there was a reduction in MBP, SVR and (at 12 hours post-ICU admission) LVSWI. Patients in the clonidine group also required a lower infusion rate of NTG postoperatively. These findings suggest that clonidine blunts the haemodynamic responses to surgery and reduces myocardial work. Tempering this is an increased requirement for intraoperative atropine administration and post-CPB cardiac pacing, although we believe these are of minimal clinical significance if temporary pacing wires are routinely used. Previous investigators have found similar haemodynamic effects with both clonidine and more selective alpha 2 -agonists (dexmedetomidine, mivazerol) during cardiac and vascular surgery [4] [5] [6] 10, 18, 19 . Previously, there has been some concern that clonidine may adversely impair LV contractility, leading to a reduction in cardiac index and DO 2 6 . Dorman et al suggested that any reduction in DO 2 may be associated with a reduction in tissue oxygen demand (VO 2 ) generated by clonidine, although they could not support their hypothesis as they did not measure mixed venous oxygen saturation in their study 6 .
Oxygen Consumption and Oxygen Delivery
Clonidine resulted in a significant reduction in DO 2 pre-induction, partly explained by a (nonsignificant) reduction in VO 2 , though associated with an increase in O 2 ER at this time. There were no significant differences between groups for these oxygen indices post-sternotomy. Following CPB there was a significant increase in VO 2 without a concomitant increase in DO 2 and so was associated with an increased O 2 ER. Previous authors have observed similar DO 2 effects with clonidine and presumed this to be secondary to clonidine's central sympatholytic effect (by reducing VO 2 ) 7 . This is the first study to actually measure the effect of clonidine on VO 2 in cardiac surgical patients and so was able to document this increase in O 2 ER. Whether this is associated with inadequate tissue perfusion remains to be determined, for although there was an association with time to tracheal extubation and ICU discharge using multivariate analyses, there was also improvement in early postoperative renal function. The eventual time course and clinical significance of this observation is unknown.
Anaesthetic, Analgesic and Sedative Drug Usage
Patients in the clonidine group required less fentanyl and propofol in response to evidence of inadequate depth of anaesthesia and less midazolam postoperatively in response to uncontrolled agitation. It could be argued that this only reflects clonidine's modulation of haemodynamic responses (as discussed above) and not an increased anaesthetic depth. But this would not explain the reduced dose of propofol required at induction, nor the lower amount of sedation required in ICU. These results are consistent with previous reports of clonidine resulting in a less agitated, more comfortable patient postoperatively 5, 7 .
To our knowledge, this is the first controlled trial to investigate a possible dose-sparing effect of clonidine in patients anaesthetized with a propofol-based technique, measuring plasma concentration of propofol. Interestingly, the resultant plasma propofol levels were similar in both groups, suggesting that clonidine's effect is not pharmacodynamic, but rather pharmacokinetic. This is most likely explained by clonidine's effect on cardiac output and organ perfusion pressure pre-CPB, leading to a reduced propofol distribution volume and drug clearance. This important finding contrasts with clonidine's welldocumented dose-sparing effect with opioid (fentanyl, morphine) and inhalational anaesthetics, which is clearly a pharmacodynamic effect 3, 4, 6, 10, 20, 21 . This predominant pharmacokinetic effect on IV anaesthetics is consistent with a report by Buhrer et al, who measured thiopentone levels in patients having noncardiac surgery after having received dexmedetomidine 22 , and Segal et al, who found similar results with alfentanil, speculating that its high hepatic extraction ratio may have made it susceptible to clonidine's haemodynamic effects 20 .
The resultant plasma propofol levels observed in this trial were lower than previously required for other types of surgery, yet are consistent with previous reports in cardiac surgery 23 . Given that opioid and benzodiazepine drugs are concurrently administered to an older population and that we did not have any reports of intraoperative awareness, it can be concluded that a propofol level of 1.9 to 2.5 µg/ml produces a satisfactory level of anaesthesia in patients undergoing cardiac surgery. This is supported by our general clinical experience in over 3,000 cardiac surgical patients receiving a similar anaesthetic regimen.
We chose to administer clonidine enterically in this study (a parenteral formulation is not available in some countries), given previous reports of efficacy and clonidine's known bioavailability exceeding 80% [3] [4] [5] [6] . Delayed absorption may have occurred but this would only have provided a longer period of effect. Given the observed differences in MBP, SVR and cardiac pacing rates persisted for at least 12 hours, we contend that we achieved satisfactory effect-site concentrations of clonidine. Nevertheless, it would have been useful to document any association between clonidine levels and adverse haemodynamic effects. Helbo-Hansen et al measured clonidine levels in 20 patients having cardiac surgery, after administration of 8 µg/kg IV 4 . They reported levels of 1 to 2 µg/ml; we would expect similar levels using our regimen.
Perioperative Renal Function
Clonidine resulted in a significant improvement in early postoperative renal function, as assessed by fourhour creatinine clearance. Kulka et al found similar beneficial effects with a lower dose of clonidine (4 µg/kg) in 48 low-risk cardiac surgical patients 9 . They also documented decreased plasma catecholamines in clonidine-treated patients, arguing that clonidine's reno-protective effect may be due to avoidance of stress-mediated renal vasoconstriction 9 .
Our results in this larger study support their contention, as we observed lower SVR for at least 12 hours after ICU admission. Clonidine is also known to inhibit antidiuretic hormone and renin release, thereby promoting a diuresis 24 . Because serum creatinine values were similar on the fifth day postoperatively, we could not demonstrate any lasting benefit on renal function with clonidine. It is possible that continuation of clonidine therapy could result in a more sustained effect (particularly in patients at increased risk of renal dysfunction), but once again this requires further investigation.
Neurohumoral Stress Response
The reduction in urinary cortisol excretion observed in patients treated with clonidine, most prominent after admission to ICU, suggests a modulation of the neurohumoral stress response. Similar effects, as well as reduced catecholamine secretion, have been previously described 4, 5, 9 . It has been argued generally that a reduction in the perioperative stress response may be associated with improved outcome after major surgery 12 , although this has not been demonstrated in cardiac surgical patients.
Quality of Life
This study found significantly improved subjective general health perceptions one month after surgery in those patients who received clonidine. To our knowledge this is the first published report of improved quality of life after cardiac surgery resulting from any anaesthetic intervention. This may be an important finding as it can be argued that changes in quality of life are the most meaningful outcome for patients after cardiac surgery. During this period, physical and psychological benefits of surgery have been welldemonstrated previously, but little is known about the changes in patients' subjective perceptions of quality of life. The Short Form 36-item Health Status Questionnaire (SF-36) was constructed to represent multidimensional health concepts, measures the full range of health states and has been widely evaluated and validated 14, 25 .
As stated above, this study was not large enough to detect significant differences in rare outcomes (such as myocardial infarction, renal failure and death). Conversely, because we performed statistical tests on multiple endpoints, there is an increased likelihood of a type I error (false positive result). We therefore urge considered interpretation by the reader and would recommend further investigation to confirm our results.
Our anaesthetic technique was propofol-based, and so results may not be generalizable to cardiac surgical patients managed with inhalation-based or highdose opioid techniques. At our institution we have a policy of encouraging early extubation and, if appropriate, early discharge from ICU. If patients are routinely sedated during the initial postoperative period and/or extubation is intentionally delayed, then different effects on recovery may be observed.
We chose to use two doses of clonidine (each 5 µg/kg), aiming to maximize the potential for reducing myocardial ischaemia 6, 12 . It is possible that a smaller dose may avoid its adverse effects and yet retain the beneficial effects 8 . Alternatively the dose chosen could be guided by the patient's preoperative HR and MBP (using a reduced dose in those considered at risk of bradycardia and hypotension), and age (using less in the elderly). The optimal dose interval and duration of therapy is unknown.
Clonidine blunts the haemodynamic responses associated with CABG surgery, particularly before bypass, and therefore allows a reduction in anaesthetic drug requirements (yet maintaining adequate depth of anaesthesia). Because clonidine is associated with some adverse effects (hypotension, bradycardia and increased pacing requirement, increased O 2 ER), it should be used with caution in patients with poor ventricular function, heart block or those prone to hypotension. This is also relevant for elderly patients, in whom we also found an increased demand for postoperative cardiac pacing. Patients may recover from surgery with less agitation, improved renal function, less stress hormone release, and can possibly be extubated earlier. Perioperative administration of clonidine is also associated with improvement in some aspects of quality of life at one month after surgery.
This study lends support to consideration of clonidine therapy in patients undergoing CABG surgery. Further research of alpha 2 -agonists in patients undergoing all types of cardiac surgery, using a variety of dosage regimens, would also be warranted.
